Literature DB >> 29773243

Impact of Diabetes and Increasing Body Mass Index Category on Left Ventricular Systolic and Diastolic Function.

Arnold C T Ng1, Francesca Prevedello2, Giulia Dolci3, Cornelis J Roos4, Roxana Djaberi4, Matteo Bertini4, See Hooi Ewe4, Christine Allman5, Dominic Y Leung5, Nina Ajmone Marsan4, Victoria Delgado4, Jeroen J Bax6.   

Abstract

BACKGROUND: Diabetes and obesity are both worldwide growing epidemics, and both are independently associated with increased risk for heart failure and death. The aim of this study was to examine the additive detrimental effect of both diabetes and increasing body mass index (BMI) category on left ventricular (LV) myocardial systolic and diastolic function.
METHODS: The present retrospective multicenter study included 653 patients (337 with type 2 diabetes and 316 without diabetes) of increasing BMI category. All patients had normal LV ejection fractions. LV myocardial systolic (peak systolic global longitudinal strain and peak systolic global longitudinal strain rate) and diastolic (average mitral annular e' velocity and early diastolic global longitudinal strain rate) function was quantified using echocardiography.
RESULTS: Increasing BMI category was associated with progressively more impaired LV myocardial function in patients with diabetes (P < .001). Patients with diabetes had significantly more impaired LV myocardial function for all BMI categories compared with those without diabetes (P < .001). On multivariate analysis, both diabetes and obesity were independently associated with an additive detrimental effect on LV myocardial systolic and diastolic function. However, obesity was associated with greater LV myocardial dysfunction than diabetes.
CONCLUSION: Both diabetes and increasing BMI category had an additive detrimental effect on LV myocardial systolic and diastolic function. Furthermore, increasing BMI category was associated with greater LV myocardial dysfunction than diabetes. As they frequently coexist together, future studies on patients with diabetes should also focus on obesity.
Copyright © 2018 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiomyopathy; Diabetes mellitus; Obesity; Ventricles

Mesh:

Year:  2018        PMID: 29773243     DOI: 10.1016/j.echo.2018.02.012

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  11 in total

1.  Modified Haller index validation and correlation with left ventricular strain in a cohort of subjects with obesity and without overt heart disease.

Authors:  Andrea Sonaglioni; Gian Luigi Nicolosi; Roberta Trevisan; Alberto Granato; Maurizio Zompatori; Michele Lombardo
Journal:  Intern Emerg Med       Date:  2022-06-26       Impact factor: 5.472

2.  Liver stiffness measurement identifies subclinical myocardial dysfunction in non-advanced non-alcoholic fatty liver disease patients without overt heart disease.

Authors:  Andrea Sonaglioni; Federica Cerini; Antonio Cerrone; Lorenzo Argiento; Gian Luigi Nicolosi; Elisabetta Rigamonti; Michele Lombardo; Maria Grazia Rumi; Mauro Viganò
Journal:  Intern Emerg Med       Date:  2022-03-17       Impact factor: 5.472

Review 3.  Metabolic Stress, Autophagy, and Cardiovascular Aging: from Pathophysiology to Therapeutics.

Authors:  Jun Ren; James R Sowers; Yingmei Zhang
Journal:  Trends Endocrinol Metab       Date:  2018-08-22       Impact factor: 12.015

Review 4.  Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging.

Authors:  Arnold C T Ng; Victoria Delgado; Barry A Borlaug; Jeroen J Bax
Journal:  Nat Rev Cardiol       Date:  2020-11-13       Impact factor: 32.419

5.  Myeloid differentiation protein 1 protected myocardial function against high-fat stimulation induced pathological remodelling.

Authors:  Cai-Jie Shen; Bin Kong; Wei Shuai; Yu Liu; Guang-Ji Wang; Min Xu; Jing-Jing Zhao; Jin Fang; Hui Fu; Xiao-Bo Jiang; He Huang
Journal:  J Cell Mol Med       Date:  2019-05-29       Impact factor: 5.310

Review 6.  Left Ventricular Diastolic Dysfunction in Type 2 Diabetes-Progress and Perspectives.

Authors:  Elena-Daniela Grigorescu; Cristina-Mihaela Lacatusu; Mariana Floria; Bogdan-Mircea Mihai; Ioana Cretu; Laurentiu Sorodoc
Journal:  Diagnostics (Basel)       Date:  2019-09-17

7.  Different Pattern of Cardiovascular Impairment in Methylmalonic Acidaemia Subtypes.

Authors:  Ying Liu; Ling Yang; Ruixue Shuai; Suqiu Huang; Bingyao Zhang; Lianshu Han; Kun Sun; Yurong Wu
Journal:  Front Pediatr       Date:  2022-02-23       Impact factor: 3.418

8.  Diabetic microvascular complications are associated with reduced global longitudinal strain independent of atherosclerotic coronary artery disease in asymptomatic patients with diabetes mellitus: a cross-sectional study.

Authors:  Gokulan Pararajasingam; Laurits Juhl Heinsen; Johanna Larsson; Thomas Rueskov Andersen; Brian Bridal Løgstrup; Søren Auscher; Jørgen Hangaard; Rasmus Møgelvang; Kenneth Egstrup
Journal:  BMC Cardiovasc Disord       Date:  2021-06-02       Impact factor: 2.298

9.  Overweight and obesity impair left ventricular systolic function as measured by left ventricular ejection fraction and global longitudinal strain.

Authors:  Peter Blomstrand; Peter Sjöblom; Mats Nilsson; Magnus Wijkman; Martin Engvall; Toste Länne; Fredrik H Nyström; Carl Johan Östgren; Jan Engvall
Journal:  Cardiovasc Diabetol       Date:  2018-08-14       Impact factor: 9.951

10.  Impact of diabetes mellitus on left ventricular longitudinal function of patients with non-ischemic dilated cardiomyopathy.

Authors:  Hidekazu Tanaka; Kazuhiro Tatsumi; Hiroki Matsuzoe; Kensuke Matsumoto; Ken-Ichi Hirata
Journal:  Cardiovasc Diabetol       Date:  2020-06-13       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.